ArticleBMC geriatrics2026
Outcome of cholecystectomy in octogenarian with concurrent cholecystitis and cholangitis receiving percutaneous cholecystostomy and subsequent interventive endoscopic retrograde cholangiopancreatography.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAcute cholecystitis (AC) with concurrent cholangitis is a life-threatening condition in elderly patients. We aimed to investigate the outcome of cholecystectomy in patients aged ≥ 80 years with moderate to severe AC who underwent percutaneous cholecystostomy and subsequent interventional endoscopic retrograde cholangiopancreatography (ERCP).
methodsBetween January 2008 and February 2021, we retrospectively enrolled 174 patients who underwent percutaneous cholecystostomy and subsequent ERCP at Taipei Veterans General Hospital. The patients were divided into cholecystectomy and non-cholecystectomy groups after discharge. Clinical outcomes including overall survival rate, recurrence rate of biliary-related events, and complications of ERCP and cholecystectomy, were analyzed. The Kaplan–Meier model was used to interpret the overall survival and cumulative recurrence rates.
resultsThere were 34 patients receiving cholecystectomy (cholecystectomy group), and 98 patients received conservative treatment (non-cholecystectomy group). The overall mortality rate and biliary-related mortality did not differ between the cholecystectomy and non-cholecystectomy groups (20.5% vs. 35.7%, p = 0.082; and 0% vs. 3%, p = 0.083, respectively). The 1-year recurrent rate, 3-year recurrent rate and 5-year recurrence rates of biliary-related events were significantly lower in the cholecystectomy group than in the non-cholecystectomy group (2.9% vs. 18.4%, p = 0.002; 5.9% vs. 20.4%, p = 0.014; 8.8% vs. 24.5%, p = 0.02, respectively). There was no significant difference in the 1-year recurrence rates of cholangitis (2,9% vs. 6.1%, p = 0.407), and pancreatitis (0% vs. 1.0%, p = 0.320). The overall ERCP-related complication rate in the elderly population was low (4%). The overall rate of surgical complications was 11.8% in the cholecystectomy group.
conclusionsCholecystectomy lowers the recurrence rate of biliary-related events in octogenarians with moderate-to-severe cholecystitis and concurrent cholangitis after percutaneous cholecystostomy and subsequent interventional ERCP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.